118 related articles for article (PubMed ID: 27793929)
1. Inhibition of Glutaminolysis Inhibits Cell Growth via Down-regulating Mtorc1 Signaling in Lung Squamous Cell Carcinoma.
Ye X; Zhou Q; Matsumoto Y; Moriyama M; Kageyama S; Komatsu M; Satoh S; Tsuchida M; Saijo Y
Anticancer Res; 2016 Nov; 36(11):6021-6029. PubMed ID: 27793929
[TBL] [Abstract][Full Text] [Related]
2. Glutaminolysis and autophagy in cancer.
Villar VH; Merhi F; Djavaheri-Mergny M; Durán RV
Autophagy; 2015; 11(8):1198-208. PubMed ID: 26054373
[TBL] [Abstract][Full Text] [Related]
3. Targeting glutaminase-mediated glutamine dependence in papillary thyroid cancer.
Yu Y; Yu X; Fan C; Wang H; Wang R; Feng C; Guan H
J Mol Med (Berl); 2018 Aug; 96(8):777-790. PubMed ID: 29942976
[TBL] [Abstract][Full Text] [Related]
4. Oridonin inhibits mTOR signaling and the growth of lung cancer tumors.
Wang YY; Lv YF; Lu L; Cai L
Anticancer Drugs; 2014 Nov; 25(10):1192-200. PubMed ID: 25075795
[TBL] [Abstract][Full Text] [Related]
5. Discovery of selective inhibitors of Glutaminase-2, which inhibit mTORC1, activate autophagy and inhibit proliferation in cancer cells.
Lee YZ; Yang CW; Chang HY; Hsu HY; Chen IS; Chang HS; Lee CH; Lee JC; Kumar CR; Qiu YQ; Chao YS; Lee SJ
Oncotarget; 2014 Aug; 5(15):6087-101. PubMed ID: 25026281
[TBL] [Abstract][Full Text] [Related]
6. Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition.
Lampa M; Arlt H; He T; Ospina B; Reeves J; Zhang B; Murtie J; Deng G; Barberis C; Hoffmann D; Cheng H; Pollard J; Winter C; Richon V; Garcia-Escheverria C; Adrian F; Wiederschain D; Srinivasan L
PLoS One; 2017; 12(9):e0185092. PubMed ID: 28950000
[TBL] [Abstract][Full Text] [Related]
7. Activation of p53 by costunolide blocks glutaminolysis and inhibits proliferation in human colorectal cancer cells.
Hu M; Liu L; Yao W
Gene; 2018 Dec; 678():261-269. PubMed ID: 30103008
[TBL] [Abstract][Full Text] [Related]
8. mTORC1 regulates glutamine metabolism.
Cancer Discov; 2013 Jul; 3(7):OF25. PubMed ID: 23847369
[TBL] [Abstract][Full Text] [Related]
9. Glutaminolysis Promotes Collagen Translation and Stability via α-Ketoglutarate-mediated mTOR Activation and Proline Hydroxylation.
Ge J; Cui H; Xie N; Banerjee S; Guo S; Dubey S; Barnes S; Liu G
Am J Respir Cell Mol Biol; 2018 Mar; 58(3):378-390. PubMed ID: 29019707
[TBL] [Abstract][Full Text] [Related]
10. Glutaminolysis feeds mTORC1.
Durán RV; Hall MN
Cell Cycle; 2012 Nov; 11(22):4107-8. PubMed ID: 23095634
[No Abstract] [Full Text] [Related]
11. Analysis of glutamine dependency in non-small cell lung cancer: GLS1 splice variant GAC is essential for cancer cell growth.
van den Heuvel AP; Jing J; Wooster RF; Bachman KE
Cancer Biol Ther; 2012 Oct; 13(12):1185-94. PubMed ID: 22892846
[TBL] [Abstract][Full Text] [Related]
12. Glutaminolysis activates Rag-mTORC1 signaling.
Durán RV; Oppliger W; Robitaille AM; Heiserich L; Skendaj R; Gottlieb E; Hall MN
Mol Cell; 2012 Aug; 47(3):349-58. PubMed ID: 22749528
[TBL] [Abstract][Full Text] [Related]
13. LRH-1-dependent programming of mitochondrial glutamine processing drives liver cancer.
Xu P; Oosterveer MH; Stein S; Demagny H; Ryu D; Moullan N; Wang X; Can E; Zamboni N; Comment A; Auwerx J; Schoonjans K
Genes Dev; 2016 Jun; 30(11):1255-60. PubMed ID: 27298334
[TBL] [Abstract][Full Text] [Related]
14. SLC1A5 mediates glutamine transport required for lung cancer cell growth and survival.
Hassanein M; Hoeksema MD; Shiota M; Qian J; Harris BK; Chen H; Clark JE; Alborn WE; Eisenberg R; Massion PP
Clin Cancer Res; 2013 Feb; 19(3):560-70. PubMed ID: 23213057
[TBL] [Abstract][Full Text] [Related]
15. The GSK3 Signaling Axis Regulates Adaptive Glutamine Metabolism in Lung Squamous Cell Carcinoma.
Momcilovic M; Bailey ST; Lee JT; Fishbein MC; Braas D; Go J; Graeber TG; Parlati F; Demo S; Li R; Walser TC; Gricowski M; Shuman R; Ibarra J; Fridman D; Phelps ME; Badran K; St John M; Bernthal NM; Federman N; Yanagawa J; Dubinett SM; Sadeghi S; Christofk HR; Shackelford DB
Cancer Cell; 2018 May; 33(5):905-921.e5. PubMed ID: 29763624
[TBL] [Abstract][Full Text] [Related]
16. Targeting ATF4-dependent pro-survival autophagy to synergize glutaminolysis inhibition.
Han S; Zhu L; Zhu Y; Meng Y; Li J; Song P; Yousafzai NA; Feng L; Chen M; Wang Y; Jin H; Wang X
Theranostics; 2021; 11(17):8464-8479. PubMed ID: 34373753
[TBL] [Abstract][Full Text] [Related]
17. Targeting ASCT2-mediated glutamine uptake blocks prostate cancer growth and tumour development.
Wang Q; Hardie RA; Hoy AJ; van Geldermalsen M; Gao D; Fazli L; Sadowski MC; Balaban S; Schreuder M; Nagarajah R; Wong JJ; Metierre C; Pinello N; Otte NJ; Lehman ML; Gleave M; Nelson CC; Bailey CG; Ritchie W; Rasko JE; Holst J
J Pathol; 2015 Jul; 236(3):278-89. PubMed ID: 25693838
[TBL] [Abstract][Full Text] [Related]
18. Cellular signaling of amino acids towards mTORC1 activation in impaired human leucine catabolism.
Schriever SC; Deutsch MJ; Adamski J; Roscher AA; Ensenauer R
J Nutr Biochem; 2013 May; 24(5):824-31. PubMed ID: 22898570
[TBL] [Abstract][Full Text] [Related]
19. Intrahippocampal glutamine administration inhibits mTORC1 signaling and impairs long-term memory.
Rozas NS; Redell JB; Pita-Almenar JD; Mckenna J; Moore AN; Gambello MJ; Dash PK
Learn Mem; 2015 May; 22(5):239-46. PubMed ID: 25878136
[TBL] [Abstract][Full Text] [Related]
20. The mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4.
Csibi A; Fendt SM; Li C; Poulogiannis G; Choo AY; Chapski DJ; Jeong SM; Dempsey JM; Parkhitko A; Morrison T; Henske EP; Haigis MC; Cantley LC; Stephanopoulos G; Yu J; Blenis J
Cell; 2013 May; 153(4):840-54. PubMed ID: 23663782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
